Changlin Lian

432 total citations
9 papers, 303 citations indexed

About

Changlin Lian is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Changlin Lian has authored 9 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Cancer Research. Recurrent topics in Changlin Lian's work include Circular RNAs in diseases (4 papers), Cancer-related molecular mechanisms research (3 papers) and Biomarkers in Disease Mechanisms (2 papers). Changlin Lian is often cited by papers focused on Circular RNAs in diseases (4 papers), Cancer-related molecular mechanisms research (3 papers) and Biomarkers in Disease Mechanisms (2 papers). Changlin Lian collaborates with scholars based in China and United States. Changlin Lian's co-authors include Hongbo Guo, Ningbo Xu, Huijun Zeng, Zhao Fu, Yang Zhao, Boyang Liu, Jian Zhou, Zhenyan He, Yanting Liu and Chenyang Wang and has published in prestigious journals such as The FASEB Journal, Medicine and Cell Death and Disease.

In The Last Decade

Changlin Lian

9 papers receiving 300 citations

Peers

Changlin Lian

MB

CR

GENET

PRM

IMMUN

Ruyou Zhang China

Paulina Vaitkienė Lithuania

Maode Wang China

Lin Pang China

Minhong Pan China

Hongzhan Liao China

Youzhi Wu China

Hong Nguyen Australia

Mariantonietta Capristo Italy

Ruyou Zhang China

Changlin Lian

287 ×1.2

MB

220 ×1.1

CR

48 ×1.0

GENET

37 ×1.2

PRM

36 ×1.2

IMMUN

Citations per year, relative to Changlin Lian Changlin Lian (= 1×) peers Ruyou Zhang

Countries citing papers authored by Changlin Lian

Since Specialization

Citations

This map shows the geographic impact of Changlin Lian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changlin Lian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changlin Lian more than expected).

Fields of papers citing papers by Changlin Lian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changlin Lian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changlin Lian. The network helps show where Changlin Lian may publish in the future.

Co-authorship network of co-authors of Changlin Lian

This figure shows the co-authorship network connecting the top 25 collaborators of Changlin Lian. A scholar is included among the top collaborators of Changlin Lian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changlin Lian. Changlin Lian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Liu, Yaxuan, Zhenyu Wu, Jiawei Gao, et al.. (2023). Integration analysis of single-cell and spatial transcriptomics reveal the cellular heterogeneity landscape in glioblastoma and establish a polygenic risk model. Frontiers in Oncology. 13. 1109037–1109037. 11 indexed citations

2.

Wu, Zhenyu, et al.. (2023). Identification and validation of a genetic risk signature associated with prognosis in clear-cell renal cell carcinoma patients. Medicine. 102(31). e34582–e34582. 1 indexed citations

3.

Lian, Changlin, Huijun Zeng, Boyang Liu, et al.. (2021). SNAP25 Inhibits Glioma Progression by Regulating Synapse Plasticity via GLS-Mediated Glutaminolysis. Frontiers in Oncology. 11. 698835–698835. 24 indexed citations

4.

Lan, Yufei, Wenhui Tang, Jue‐Yu Zhou, et al.. (2021). Exosome-mediated transfer of MIF confers temozolomide resistance by regulating TIMP3/PI3K/AKT axis in gliomas. Molecular Therapy — Oncolytics. 22. 114–128. 33 indexed citations

5.

Lian, Changlin, Xiang-Yang Zhong, Zhenyan He, et al.. (2021). Pentraxin 3 secreted by human adipose‐derived stem cells promotes dopaminergic neuron repair in Parkinson's disease via the inhibition of apoptosis. The FASEB Journal. 35(7). e21748–e21748. 16 indexed citations

6.

Zhou, Jian, Chenyang Wang, Zhao Fu, et al.. (2020). LncRNA SOX2OT promotes temozolomide resistance by elevating SOX2 expression via ALKBH5-mediated epigenetic regulation in glioblastoma. Cell Death and Disease. 11(5). 384–384. 85 indexed citations

7.

Xu, Ningbo, Boyang Liu, Changlin Lian, et al.. (2018). Long noncoding RNA AC003092.1 promotes temozolomide chemosensitivity through miR-195/TFPI-2 signaling modulation in glioblastoma. Cell Death and Disease. 9(12). 1139–1139. 65 indexed citations

8.

Zeng, Huijun, Yang Zhao, Ningbo Xu, et al.. (2017). Connective tissue growth factor promotes temozolomide resistance in glioblastoma through TGF-β1-dependent activation of Smad/ERK signaling. Cell Death and Disease. 8(6). e2885–e2885. 41 indexed citations

9.

Zeng, Huijun, Ningbo Xu, Yanting Liu, et al.. (2017). Genomic profiling of long non-coding RNA and mRNA expression associated with acquired temozolomide resistance in glioblastoma cells. International Journal of Oncology. 51(2). 445–455. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact